TechNavio's analysts forecast the Global Alzheimer's Drugs market to grow at a CAGR of 3.26 percent over the period 2012–2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Alzheimer's Drugs market has also been witnessing the availability of improved diagnostics. However, numerous patent expiries could pose a challenge to the growth of this market.... Research Beam Model: Research Beam Product ID: 16590 2000 USD New
Global Alzheimer's Drugs Market 2012?2016
 
 

Global Alzheimers Drugs Market 2012-2016

  • Category : Healthcare
  • Published On : May   2013
  • Pages : 51
  • Publisher : Technavio
 
 
 

TechNavio's analysts forecast the Global Alzheimer's Drugs market to grow at a CAGR of 3.26 percent over the period 2012–2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Alzheimer's Drugs market has also been witnessing the availability of improved diagnostics. However, numerous patent expiries could pose a challenge to the growth of this market. 



TechNavio's report, the Global Alzheimer's Drugs market 2012–2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Alzheimer’s Drugs market in the Americas, the EMEA, and the APAC regions, its market landscape, and growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.



The key vendors dominating this market space include Eisai Co., Ltd., Forest Laboratories Inc., H. Lundbeck A/S., Novartis AG, and Pfizer Inc.



Key questions answered in this report: 

What will the market size be in 2016 and at what will be the growth rate?

What are key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by key vendors?

What are the strengths and weaknesses of each of these key vendors?



You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.


1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology


4.1. Market Research Process

4.2. Research Design

4.3. Research Methodology

5. Scope of the Report

5.1. Market Overview

5.2. Product Offerings

5.3. Product Profiles

6. Market Landscape

6.1. Global Alzheimer's Drugs market 2012–2016 

6.1.1. Market Size and Forecast 

6.1.2. Market Size and Forecast  For EU

7. Five Force Analysis

8. Geographical Segmentation

9. Rate of Incidence and Prevalence

10. Vendor Landscape

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges


16. Market Trends

17. Key Vendor Analysis


17.1. Forest Laboratories Inc.

17.1.1. Business Overview

17.1.2. Key Information

17.1.3. SWOT Analysis

17.2. Eisai Co., Ltd.

17.2.1. Business Overview

17.2.2. Key Information

17.2.3. SWOT Analysis

17.3. Novartis AG

17.3.1. Business Overview

17.3.2. Key Information

17.3.3. SWOT Analysis

17.4. H. Lundbeck A/S

17.4.1. Business Overview

17.4.2. Key Information

17.4.3. SWOT Analysis

17.5. Pfizer Inc.

17.5.1. Business Overview

17.5.2. Key Information

17.5.3. SWOT Analysis



18. Other Reports in this Series



List of Exhibits:

Exhibit 1: Market Research Methodology

Exhibit 2: Global Alzheimer's Drugs Market 2012–2016 (US$ billion)

Exhibit 3: Alzheimer's Drugs Market in the EU 2012-2016 (US$ billion)

Exhibit 4: Global Alzheimer’s Drugs Market by Geographical Segmentation   2012



PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 

Related Reports

REQUEST SAMPLE    ASK FOR DISCOUNT